✦ LIBER ✦

Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia

✍ Scribed by E. Dahl; L. L. Gluud; N. Kimer; A. Krag

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

154 SAFETY AND EFFICACY OF VAPTANS IN CI

✍ E. Dahl; L.L. Gluud; A. Krag 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Spironolactone alone or in combination w

✍ Justiniano Santos; Ramon Planas; Albert Pardo; Rosa Durández; Eduard Cabré; Rosa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

A multicenter, open-label, dose-ranging

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 329 KB

Clinical trial: short-term effects of co

✍ P. GINÈS; F. WONG; H. WATSON; R. TERG; R. BRUHA; J.-P. ZARSKI; F. DUDLEY; FOR TH 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Assessment of the efficacy and safety of

✍ Joseph G. Verbalis; David Zeltser; Neila Smith; Abhijit Barve; Masakazu Andoh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Erratum to: A multicenter, open-label, d

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 75 KB